drugset / Trial / NCT02348398
Phase II Study of Pazopanib and Topotecan in Cervical Cancer
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if the combination of topotecan and pazopanib can help to control recurrent cervical cancer. The safety of the study drug combination will also be studied.
Timeline
- Start
- 2016-08
- Primary completion
- 2019-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pazopanib | Small molecule | 600 mg | Oral |
| Subject | Topotecan | Small molecule | 0.25 mg | Oral |